Clinical Trial Update: Open Multi-centre Investigation to Evaluate Signs and Symptoms of Local Inflammation/Infection on Chronic Ulcers and Partial Thickness Burns When Using Mepilex Border Ag as an Anti-microbial Wound Dressing [Phase 3]

View source ↗

Summary

Phase 3 open multicenter trial evaluating Mepilex Border Ag, an antimicrobial wound dressing, for reducing signs and symptoms of local inflammation/infection in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burn Injuries
• Ulcers

Drugs mentioned

• Mepilex Border Ag (silver-impregnated antimicrobial wound dressing)

Snippet

Sponsor: Molnlycke Health Care AB | Conditions: Inflammation, Burns | Phase 3 | Status: COMPLETED | Results posted: 2013-02-26